Hans-Jörg Senn

2.3k total citations · 1 hit paper
9 papers, 1.6k citations indexed

About

Hans-Jörg Senn is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hans-Jörg Senn has authored 9 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hans-Jörg Senn's work include Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (3 papers) and Estrogen and related hormone effects (2 papers). Hans-Jörg Senn is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (3 papers) and Estrogen and related hormone effects (2 papers). Hans-Jörg Senn collaborates with scholars based in Switzerland, Italy and United States. Hans-Jörg Senn's co-authors include Alan S. Coates, Aron Goldhirsch, Richard D. Gelber, John H. Glick, Beat Thürlimann, William C. Wood, Christoph Hürny, Jürg Bernhard, W. Eiermann and Vicente Valero and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Medical Care.

In The Last Decade

Hans-Jörg Senn

8 papers receiving 1.5k citations

Hit Papers

Meeting Highlights: Updat... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans-Jörg Senn Switzerland 8 1.0k 873 361 312 252 9 1.6k
Robert P. Gray United States 15 859 0.8× 718 0.8× 352 1.0× 174 0.6× 197 0.8× 26 1.3k
J. Collins Switzerland 16 806 0.8× 780 0.9× 322 0.9× 325 1.0× 203 0.8× 18 1.3k
Christopher Wale United Kingdom 9 1.2k 1.1× 987 1.1× 291 0.8× 553 1.8× 269 1.1× 9 1.8k
Javaid Iqbal Canada 15 782 0.8× 1.1k 1.2× 381 1.1× 430 1.4× 286 1.1× 23 1.8k
Irma Fredriksson Sweden 22 805 0.8× 946 1.1× 263 0.7× 231 0.7× 281 1.1× 64 1.5k
Mayada R. Bani Germany 21 816 0.8× 597 0.7× 315 0.9× 135 0.4× 324 1.3× 42 1.6k
Ellen Schlichting Norway 21 676 0.7× 834 1.0× 224 0.6× 457 1.5× 420 1.7× 44 1.6k
Knud Andersen Denmark 18 1.0k 1.0× 772 0.9× 500 1.4× 241 0.8× 102 0.4× 31 1.4k
Jean Robert Canada 13 1.2k 1.1× 1.2k 1.3× 575 1.6× 207 0.7× 218 0.9× 14 2.1k
C.-M. Rudenstam Sweden 18 746 0.7× 1.2k 1.3× 248 0.7× 437 1.4× 242 1.0× 28 1.7k

Countries citing papers authored by Hans-Jörg Senn

Since Specialization
Citations

This map shows the geographic impact of Hans-Jörg Senn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans-Jörg Senn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans-Jörg Senn more than expected).

Fields of papers citing papers by Hans-Jörg Senn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans-Jörg Senn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans-Jörg Senn. The network helps show where Hans-Jörg Senn may publish in the future.

Co-authorship network of co-authors of Hans-Jörg Senn

This figure shows the co-authorship network connecting the top 25 collaborators of Hans-Jörg Senn. A scholar is included among the top collaborators of Hans-Jörg Senn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans-Jörg Senn. Hans-Jörg Senn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kaufmann, Manfred, Gϋnter von Minckwitz, Jonas Bergh, et al.. (2013). Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades. Archives of Gynecology and Obstetrics. 288(6). 1203–1212. 10 indexed citations
2.
Goldhirsch, Aron, William C. Wood, Richard D. Gelber, et al.. (2003). Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer. Journal of Clinical Oncology. 21(17). 3357–3365. 537 indexed citations breakdown →
3.
Kaufmann, Manfred, Gϋnter von Minckwitz, Roy E. Smith, et al.. (2003). International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and Recommendations. Journal of Clinical Oncology. 21(13). 2600–2608. 265 indexed citations
4.
Crivellari, Diana, Karen N. Price, Richard D. Gelber, et al.. (2003). Adjuvant Endocrine Therapy Compared With No Systemic Therapy for Elderly Women With Early Breast Cancer: 21-Year Results of International Breast Cancer Study Group Trial IV. Journal of Clinical Oncology. 21(24). 4517–4523. 50 indexed citations
5.
Goldhirsch, Aron, John H. Glick, Richard D. Gelber, Alan S. Coates, & Hans-Jörg Senn. (2001). Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Journal of Clinical Oncology. 19(18). 3817–3827. 459 indexed citations
6.
Hürny, Christoph, Jürg Bernhard, Alan S. Coates, et al.. (1996). Responsiveness of a Single-Item Indicator Versus a Multi-Item Scale. Medical Care. 34(3). 234–248. 78 indexed citations
7.
Hürny, Christoph, Jürg Bernhard, M. Bacchi, et al.. (1993). The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Supportive Care in Cancer. 1(4). 200–208. 82 indexed citations
8.
Goldhirsch, Aron, Richard D. Gelber, Monica Castiglione, & Hans-Jörg Senn. (1993). IBCSG's reply. The Lancet. 342(8886-8887). 1551–1551. 1 indexed citations
9.
Hürny, Christoph, Jürg Bernhard, Richard D. Gelber, et al.. (1992). Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. European Journal of Cancer. 28(1). 118–124. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026